BETRF (BetterLife Pharma) Tariff Resilience Score: 4/10 (As of Jul. 02, 2026)


BETRF BetterLife Pharma Inc BETRF
28 GF Score
Price $0.13
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Tariff Resilience Score?

BetterLife Pharma BETRF +8.85% 28 Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,374 Biotechnology companies, BetterLife Pharma ranks better than 52.33% on this metric.

BetterLife Pharma has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

BetterLife Pharma has As a pharmaceutical company, BetterLife Pharma relies on global supply chains for raw materials. Its manufacturing and sales are internationally dispersed, making it vulnerable to tariffs. However, the industry often benefits from specific exemptions, providing some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes BetterLife Pharma might have Average Resilient.

BetterLife Pharma  (OTCPK:BETRF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

BetterLife Pharma Tariff Resilience Score Related Terms

BETRF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, BetterLife Pharma's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Tariff Resilience Score falls into.


BETRF
28GF Score
BetterLife Pharma Inc BETRF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
BetterLife Pharma (BETRF) has a Tariff Resilience Score of 4 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, BetterLife Pharma ranks #655 out of 1374 companies in the Biotechnology industry, placing it in the top 47.7%.
Is BetterLife Pharma's Tariff Resilience Score too high?
BetterLife Pharma's current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. BetterLife Pharma's value of 4 is 0% at this industry median. Based on the distribution chart, BetterLife Pharma ranks #655 out of 1374 companies in the Biotechnology industry, which is above the industry midpoint. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BetterLife Pharma ranks #655 out of 1374 companies for Tariff Resilience Score. This puts BetterLife Pharma in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. BetterLife Pharma's value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BetterLife Pharma's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BetterLife Pharma's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score

Get the complete analysis for BETRF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price